BAX Baxter International Inc

Price (delayed)

$46

Market cap

$23.19B

P/E Ratio

N/A

Dividend/share

$1.15

EPS

-$4.71

Enterprise value

$38.47B

Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, it has been operating ...

Highlights
The revenue is up by 18% year-on-year and by 3.9% since the previous quarter
The gross profit has grown by 9% year-on-year but it has declined by 3.4% since the previous quarter
Baxter International's debt has soared by 162% YoY
The company's equity fell by 38% QoQ and by 37% YoY

Key stats

What are the main financial stats of BAX
Market
Shares outstanding
504.12M
Market cap
$23.19B
Enterprise value
$38.47B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.19
Price to sales (P/S)
1.57
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.61
Earnings
Revenue
$14.74B
EBIT
-$1.95B
EBITDA
-$640M
Free cash flow
$751M
Per share
EPS
-$4.71
Free cash flow per share
$1.49
Book value per share
$10.99
Revenue per share
$29.25
TBVPS
$28.57
Balance sheet
Total assets
$27.97B
Total liabilities
$22.39B
Debt
$16.89B
Equity
$5.54B
Working capital
$4.1B
Liquidity
Debt to equity
3.05
Current ratio
2.11
Quick ratio
1.12
Net debt/EBITDA
-23.88
Margins
EBITDA margin
-4.3%
Gross margin
36.2%
Net margin
-16.1%
Operating margin
-13%
Efficiency
Return on assets
-7.5%
Return on equity
-29.2%
Return on invested capital
-7.4%
Return on capital employed
-8.1%
Return on sales
-13.3%
Dividend
Dividend yield
2.5%
DPS
$1.15
Payout ratio
N/A

BAX stock price

How has the Baxter International stock price performed over time
Intraday
-0.35%
1 week
4.83%
1 month
-9.52%
1 year
-45.65%
YTD
-9.75%
QTD
-9.75%

Financial performance

How have Baxter International's revenue and profit performed over time
Revenue
$14.74B
Gross profit
$5.34B
Operating income
-$1.91B
Net income
-$2.38B
Gross margin
36.2%
Net margin
-16.1%
The operating margin has plunged by 194% YoY
The revenue is up by 18% year-on-year and by 3.9% since the previous quarter
The gross profit has grown by 9% year-on-year but it has declined by 3.4% since the previous quarter
The gross margin is down by 8% year-on-year and by 7% since the previous quarter

Growth

What is Baxter International's growth rate over time

Valuation

What is Baxter International stock price valuation
P/E
N/A
P/B
4.19
P/S
1.57
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.61
The company's equity fell by 38% QoQ and by 37% YoY
BAX's P/B is 13% below its 5-year quarterly average of 4.8 and 4.8% below its last 4 quarters average of 4.4
BAX's P/S is 54% below its 5-year quarterly average of 3.4 and 40% below its last 4 quarters average of 2.6
The revenue is up by 18% year-on-year and by 3.9% since the previous quarter

Efficiency

How efficient is Baxter International business performance
The ROIC has plunged by 170% YoY

Dividends

What is BAX's dividend history
DPS
$1.15
Dividend yield
2.5%
Payout ratio
N/A
Recent dividends

Financial health

How did Baxter International financials performed over time
The total assets is 25% more than the total liabilities
The total liabilities has soared by 104% YoY but it has decreased by 2.4% from the previous quarter
The total assets has grown by 41% YoY but it has contracted by 12% from the previous quarter
Baxter International's debt has soared by 162% YoY
The debt to equity has surged by 57% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.